Conclusively, our MR analysis is generally in agreement with the two prospective observational studies, does not support the hypothesis that circulating resistin concentrations are associated to risk of CRC, and suggests that resistin is a marker of existing tumors rather than a causal risk factor. This evidence concerns the gene RETN and colorectal carcinoma.